Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 To be or not to be--obese.

Literature DB >> 21937750

To be or not to be--obese.

Stuart Maudsley¹, Bronwen Martin, Josephine M Egan.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2011 PMID： 21937750 PMCID： PMC3176656 DOI： 10.1210/en.2011-1615

Source DB: PubMed Journal: Endocrinology ISSN： 0013-7227 Impact factor: 4.736

× No keyword cloud information.

40 in total

1. Targeting opioid receptors: A new treatment for brain disorders.

Authors: Shafiqur Rahman
Journal: CNS Neurol Disord Drug Targets Date: 2010-04 Impact factor: 4.388

Review 2. Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders.

Authors: Liyun Wang; Bronwen Martin; Randall Brenneman; Louis M Luttrell; Stuart Maudsley
Journal: J Pharmacol Exp Ther Date: 2009-08-10 Impact factor: 4.030

3. Leptin potentiates the anti-obesity effects of rimonabant.

Authors: Carine M Boustany-Kari; V Margaret Jackson; Colleen P Gibbons; Andrew G Swick
Journal: Eur J Pharmacol Date: 2011-03-01 Impact factor: 4.432

4. Risk of suicide after long-term follow-up from bariatric surgery.

Authors: Hilary A Tindle; Bennet Omalu; Anita Courcoulas; Marsha Marcus; Jennifer Hammers; Lewis H Kuller
Journal: Am J Med Date: 2010-09-16 Impact factor: 4.965

5. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.

Authors: Daniela da Fonseca Pacheco; André Klein; Andréa Castro Perez; Cinthia Mara da Fonseca Pacheco; Janetti Nogueira de Francischi; Gláucia Maria Lopes Reis; Igor Dimitri Gama Duarte
Journal: Br J Pharmacol Date: 2009-07-07 Impact factor: 8.739

6. Pharmacotherapy for obesity.

Authors: Mingfang Li; Bernard M Y Cheung
Journal: Br J Clin Pharmacol Date: 2009-12 Impact factor: 4.335

7. Prevalence and trends in obesity among US adults, 1999-2008.

Authors: Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Lester R Curtin
Journal: JAMA Date: 2010-01-13 Impact factor: 56.272

Review 8. The pharmacological treatment and management of obesity.

Authors: Syed Sufyan Hussain; Stephen Robert Bloom
Journal: Postgrad Med Date: 2011-01 Impact factor: 3.840

9. Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells.

Authors: Wook Kim; Máire E Doyle; Zhuo Liu; Qizong Lao; Yu-Kyong Shin; Olga D Carlson; Hee Seung Kim; Sam Thomas; Joshua K Napora; Eun Kyung Lee; Ruin Moaddel; Yan Wang; Stuart Maudsley; Bronwen Martin; Rohit N Kulkarni; Josephine M Egan
Journal: Diabetes Date: 2011-02-23 Impact factor: 9.461

Review 6. GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease.

Authors: Hanne Leysen; Deborah Walter; Bregje Christiaenssen; Romi Vandoren; İrem Harputluoğlu; Nore Van Loon; Stuart Maudsley
Journal: Int J Mol Sci Date: 2021-12-13 Impact factor: 5.923

6 in total

To be or not to be--obese.

1. Targeting opioid receptors: A new treatment for brain disorders.

Review 2. Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders.

3. Leptin potentiates the anti-obesity effects of rimonabant.

4. Risk of suicide after long-term follow-up from bariatric surgery.

5. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.

6. Pharmacotherapy for obesity.

7. Prevalence and trends in obesity among US adults, 1999-2008.

Review 8. The pharmacological treatment and management of obesity.

9. Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells.

Review 10. Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists.

Review 1. The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease.

2. Metabolic context regulates distinct hypothalamic transcriptional responses to antiaging interventions.

3. Plurigon: three dimensional visualization and classification of high-dimensionality data.

4. Long-term artificial sweetener acesulfame potassium treatment alters neurometabolic functions in C57BL/6J mice.

5. BRET Biosensor Analysis of Receptor Tyrosine Kinase Functionality.

Review 6. GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease.